Release Date: 14/01/11 15:54 Summary: GGG Resources PLC - Replacement Prospectus Price Sensitive: No Download Document 6.26MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%